FemSeven Conti Patches

FemSeven Conti Patches are a combined HRT treatment that delivers regulated doses of oestrogen and progesterone. These patches are designed for women experiencing menopause symptoms such as hot flushes, vaginal dryness, and low mood, or for preventing osteoporosis in postmenopausal women.

FemSeven Conti Patches contain:

• Estradiol hemihydrate: A bioidentical oestrogen that mimics the body's natural hormones to reduce menopause symptoms.
• Levonorgestrel: A synthetic form of progesterone that protects the uterus by regulating the endometrial lining and reducing the risk of womb cancer.

The patches release these hormones through the skin into the bloodstream, replenishing the hormonal levels lost during menopause.

1. Application Instructions:
   • Apply one patch weekly to clean, dry, hairless skin (e.g., buttocks or hips).
   • Avoid the breasts or broken skin.
   • Press down firmly for 30 seconds to ensure adhesion.
2. Weekly Replacement:
   • Replace the patch every 7 days, rotating application sites to prevent irritation.
   • If the patch falls off, replace it immediately and resume your schedule.
3. Forgotten Patch:
   • Apply a new patch as soon as you remember, then continue your original schedule.

Common Side Effects (1 in 10 Women):

• Bleeding or spotting between cycles
• Skin irritation at the application site
• Breast tenderness
• Headaches
• Indigestion

Serious Side Effects:

• Blood clots (e.g., leg pain/swelling or chest pain)
• Stroke symptoms (e.g., sudden numbness, difficulty speaking)
• Breast or endometrial cancer

Seek immediate medical attention if you experience severe or unusual symptoms.

• Do Not Use FemSeven Conti If You Have:

  • A history of breast or womb cancer
  • Blood clotting disorders or previous blood clots
  • Liver disease or unexplained vaginal bleeding
  • A history of heart attack or stroke

• Consult Your Doctor If You Have:

  • Uterine fibroids, endometriosis, or endometrial hyperplasia
  • High blood pressure or elevated cholesterol levels
  • Diabetes, gallstones, migraines, or epilepsy
  • A family history of hormone-sensitive cancers

• Surgery:

  • Stop using FemSeven Conti 4–6 weeks before surgery to reduce blood clot risk.